Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002906 |
---|---|
Receipt number | R000003468 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for malignant brain tumor patients |
Date of disclosure of the study information | 2009/12/16 |
Last modified on | 2019/12/06 13:26:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/12/16 12:18:10 | ||
2 | Update | 2010/07/16 14:23:30 | Organization1 Tel1 Email1 |
|
3 | Update | 2014/07/09 11:38:43 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name TEL Institute Institute Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2014/12/12 10:33:29 | Key secondary outcomes |
|
5 | Update | 2014/12/12 10:35:02 | Interventions/Control_1 Key inclusion criteria |
|
6 | Update | 2019/01/07 10:49:26 | Recruitment status |
|
7 | Update | 2019/12/06 13:26:15 | Recruitment status Date of IRB Last follow-up date |